Nonviral delivery of self-amplifying RNA vaccines. - Wikidata - wikimedia - TriplyDB

Nonviral delivery of self-amplifying RNA vaccines.

Nonviral delivery of self-amplifying RNA vaccines.

http://www.wikidata.org/entity/Q36221799

about

Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines Advances in structure-based vaccine design Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Vaccines for the 21st century Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles mRNA capping: biological functions and applications Replicon RNA Viral Vectors as Vaccines Delivering vaccines to the people who need them most Antiviral regulation in porcine monocytic cells at different activation states Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice.Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design.mRNA vaccine delivery using lipid nanoparticles.The notorious R.N.A. in the spotlight - drug or target for the treatment of disease Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.A cationic nanoemulsion for the delivery of next-generation RNA vaccines.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.Managing diabetes with nanomedicine: challenges and opportunities Vaccines against respiratory syncytial virus: The time has finally come.Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose An in silico approach to design potential siRNA molecules for ICP22 (US1) gene silencing of different strains of human herpes simplex 1.Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system.Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.RNA replicon delivery via lipid-complexed PRINT protein particles.Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Vaccine design: emerging concepts and renewed optimism.Advances in and the potential of vaccines for respiratory syncytial virus.Cancer vaccination by electro-gene-transfer.Engineering synthetic vaccines using cues from natural immunity.Lipid-based nanoparticles in the systemic delivery of siRNA.Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs Messenger RNA (mRNA) nanoparticle tumour vaccination

P2860

Q26773073-9F4315F2-05B1-4085-B2EB-35B2C864A910 Q26824545-6468397E-D6D0-418D-9153-C91D31A9275C Q26859021-833F4009-11CA-450D-8560-E5C5118B396A Q26861563-6E7DB5FD-0D97-4F44-95E4-07DA9317DCAC Q27007529-21218EFD-0228-4713-BA7E-D2119A068049 Q27027078-28E4D43D-6980-4097-9F30-AEA6D24CFF77 Q27469050-216AC7CB-6763-41EF-8013-073D1DB8D1B0 Q28076639-3F6235C4-886B-4408-B721-879A3C1227E9 Q28082744-DFD20080-DEB1-475F-97E2-9531D6D0220F Q28394994-682A7FE0-29F5-43DD-BFA0-A237208B1908 Q30375250-9E317E58-FE02-439B-A40F-BDE30734EF25 Q30380290-1D6F9BAC-EBFC-4D13-849B-A1B543259E02 Q30431343-EEB710A6-E48D-4E4B-8054-F49A04BBBA2D Q33646948-421FA4CC-8BC0-439C-84EE-4EE53EB4ACCB Q33711685-2A4A9D7F-B562-4846-879E-B90FA1929DD8 Q33739733-3C4D9F05-2C1D-4206-8EE3-97F5728DC194 Q35558828-72AC99DB-1407-4BA1-B2F4-72F42D4C87A3 Q35600305-21A6A566-305B-4973-A602-DA4539A4C9CD Q35826688-FBD2CBCD-1231-4261-B472-E5DDB1AE4DA4 Q36104042-D02F1069-3176-496A-A67E-527B72479F45 Q36157283-EDB5581D-A22E-4A2B-8C3D-7E50F1269013 Q36218294-3C62CF4E-5FBE-4040-B37E-5087F32582F5 Q36574654-79451FF1-52F4-4625-B3E4-ED5115BE1751 Q37018347-00DCAB04-6219-45A2-85BF-9B0C930144D2 Q37126611-B6B303F2-A82E-44CC-BC86-F0075ADEDAE8 Q37134388-CB5E9888-D9FE-4692-A0B5-8BFD0CFD283F Q37330601-661DC580-C69A-4727-8766-CBCB44F33A23 Q37607987-62BD7BA0-5CA0-4ACC-B3DC-26AF00D866F7 Q37628162-062A5634-44BE-4F4B-A0EA-5234A1C36CE3 Q37681765-46ABFD03-D673-45DE-BDF8-66BF7D97E537 Q37737615-135A617F-4A54-4251-8052-072E56487905 Q38087785-F782B804-D0FC-4EA5-B7E1-4836BA84B757 Q38130514-97A45015-593F-4B1D-A268-7F1F254BA9E7 Q38143182-2F44BB6D-6BC7-4F5A-B32C-ED401E686C73 Q38154804-59E0DAA7-0004-4F21-A8A3-08CFD4FF84D2 Q38172634-8916F2C3-9A11-4DE2-8CF1-748023111BA8 Q38199151-054B873A-6009-41DD-961B-1DF7F73A23F6 Q38205757-F402FAE5-7943-43BD-8576-A5091EE063DC Q38206520-5C3A02AA-A9D6-414F-8248-1BC88F943FF3 Q38218147-933A8736-307E-4455-80EB-A17AA5667FE6

P2860

Nonviral delivery of self-amplifying RNA vaccines.

http://www.wikidata.org/entity/Q36221799

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Nonviral delivery of self-amplifying RNA vaccines.

@ast

Nonviral delivery of self-amplifying RNA vaccines.

@en

type

label

Nonviral delivery of self-amplifying RNA vaccines.

@ast

Nonviral delivery of self-amplifying RNA vaccines.

@en

prefLabel

Nonviral delivery of self-amplifying RNA vaccines.

@ast

Nonviral delivery of self-amplifying RNA vaccines.

@en

P1433

Q36221799-75704A83-905D-4259-8B24-614CE29F2214

P1476

Q36221799-8D14B5E9-614D-42D9-A0AB-F3117722CBAA

P2093

Q36221799-1B8E5771-8385-49DF-BD55-EB05FCF2B98F

Q36221799-2F7782E2-BE3B-45A5-9452-E771E46F5F73

Q36221799-35382276-6706-412E-A4CA-F8880A84899F

Q36221799-36E6B67E-D290-4A3A-B730-49D82A95BCB5

Q36221799-4062E046-DF39-4FB8-A9AC-3D8873AFAD80

Q36221799-42C8169B-C4D5-4C87-9101-70D4940275DC

Q36221799-563D5982-1C43-421E-B5E0-C6291F874BE8

Q36221799-602F66DA-4784-46EC-A62B-2CBFF4AFF314

Q36221799-64B323BE-EDB8-4D98-A627-180B91CA4A49

Q36221799-67D6AA9B-74D5-4A39-83A1-FD5030B9E38C

P2860

Q36221799-071C15A6-46FA-45D3-94D9-EF7653B973FC

Q36221799-13CA9A88-7699-403E-89B5-D6743418B6CF

Q36221799-1C06EC53-9DE1-4D3D-9151-1799996D00B0

Q36221799-2968CA7C-A286-46BB-AB0E-112D15E456EF

Q36221799-30465B28-0380-4C2D-BA29-2959A38B108B

Q36221799-36BB7CD5-F205-4AD1-9BCF-23B3E9AAEBC2

Q36221799-46B2C5F2-6212-4047-B1B3-557089608F82

Q36221799-4AAE1625-7B7D-4954-8ED3-FA78BEBA2B15

Q36221799-4D8A6FDD-EDFD-4564-95E0-EB5CCA2D2A83

Q36221799-58B65220-92E6-4B06-8E3E-1FB023F5BA6C

P304

Q36221799-12827712-3051-46F6-B246-4AEC32890A24

P31

Q36221799-FFDB4492-9683-49FD-8E0F-A2979AD3D9C0

P356

Q36221799-A3955098-1120-4FB3-9E20-0B11A109D373

P407

Q36221799-9A45B8E1-65F3-4038-B74A-793FCB39E75A

P433

Q36221799-61BE026F-40BA-43BB-81D3-797E38FD3D0A

P478

Q36221799-0BFF11FA-FD82-47CB-8F21-CE34F97710BB

P50

Q36221799-FEB85D04-446E-431C-992E-1FC61A0FB797

P577

Q36221799-6D4DECC6-494D-40F0-848A-0D426DED0DBB

P5875

Q36221799-C11B6160-CF44-4475-B508-DFD8725A7DE7

P698

Q36221799-01672D77-2FA0-40F9-8153-6722BB230728

P932

Q36221799-BEFCB21F-9043-4EEC-8C08-260FEA4A20CF

P356

PNAS.1209367109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nonviral delivery of self-amplifying RNA vaccines.

@en

P2093

Andrew J Geall

http://www.w3.org/2001/XMLSchema#string

Armin Hekele

http://www.w3.org/2001/XMLSchema#string

Ayush Verma

http://www.w3.org/2001/XMLSchema#string

Christian W Mandl

http://www.w3.org/2001/XMLSchema#string

Christine A Shaw

http://www.w3.org/2001/XMLSchema#string

Clayton W Beard

http://www.w3.org/2001/XMLSchema#string

Derek T O'Hagan

http://www.w3.org/2001/XMLSchema#string

Gillis R Otten

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Ulmer

http://www.w3.org/2001/XMLSchema#string

Kaustuv Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

Intradermal electroporation of naked replicon RNA elicits strong immune responses

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.

Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

Non-viral amplification systems for gene transfer: vectors based on alphaviruses.

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo.

Alphavirus vectors and vaccination.

P304

14604-14609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1209367109

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230712385

http://www.w3.org/2001/XMLSchema#string

P698

22908294

http://www.w3.org/2001/XMLSchema#string

P932

3437863

http://www.w3.org/2001/XMLSchema#string